Gary I Sinclair MD

HIV/AIDS Medicine

AIDS ARMS Inc.

219 Sunset AveSte 116ADallas, TX 75208
Phone+1 972-807-7370
Fax+1 972-807-7381

Dr. Sinclair is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sinclair's full profile Already have an account?

Summary

Dr. Gary Sinclair is an infectious disease specialist based in Dallas, TX, with a subspecialty in HIV/AIDS Medicine. He completed his fellowship and residency at Case Western Reserve University/University Hospitals Cleveland Medical Center. Dr. Sinclair has contributed significantly to the literature, including publications in the Journal of Clinical Epidemiology and Open Forum Infectious Diseases. He has participated in clinical trials such as the study on HIV Acquired Lipodystrophy. Dr. Sinclair has received numerous CMS Meaningful Use Stage 1 and Stage 2 certifications.

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1997 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
Case Western Reserve University School of MedicineClass of 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ND State Medical License 2013 - 2028
TX State Medical License 2000 - 2028
IN State Medical License 2010 - 2015
NJ State Medical License 2010 - 2015
MI State Medical License 2010 - 2014
OH State Medical License 1996 - 2014
PA State Medical License 2006 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2014, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2017
CMS Meaningful Use Stage 2 Certification Centricity Practice Solution, GE Healthcare, 2014, 2017

Clinical Trials

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) Start of enrollment: 2009 Oct 01
Completed
Not Applicable

Publications & Presentations

PubMed

11 citations
Clinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an ...
Dima Dandachi, Cindy Garris, David Richardson, Gary Sinclair, Doug Cunningham
Open Forum Infectious Diseases. 2025-05-01
4 citations
Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the...
Tahilin Sanchez Karver, Miguel Pascual-Bernaldez, Alessandro Berni, Ahmed Hnoosh, Antonella Castagna
AIDS Patient Care and Stds. 2023-01-01
33 citations
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiv...
Maggie Czarnogorski, Cindy P Garris, Marybeth Dalessandro, Ronald D'Amico, Toyin Nwafor
Journal of the International AIDS Society. 2022-09-01